InfuSystem (NYSEAMERICAN:INFU) Lowered to “Buy” at StockNews.com

InfuSystem (NYSEAMERICAN:INFU) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Monday.

InfuSystem Trading Down 1.4 %

Shares of INFU stock opened at $7.51 on Monday. InfuSystem has a 1-year low of $7.42 and a 1-year high of $11.44. The company has a current ratio of 1.95, a quick ratio of 1.54 and a debt-to-equity ratio of 0.56. The firm has a market cap of $159.66 million, a PE ratio of 250.42 and a beta of 1.24.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Punch & Associates Investment Management Inc. grew its stake in InfuSystem by 3.2% in the third quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock valued at $9,061,000 after purchasing an additional 28,807 shares in the last quarter. Wasatch Advisors LP grew its stake in InfuSystem by 3.4% in the fourth quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock valued at $8,923,000 after purchasing an additional 27,881 shares in the last quarter. Ranger Investment Management L.P. grew its stake in InfuSystem by 4.7% in the fourth quarter. Ranger Investment Management L.P. now owns 689,842 shares of the medical instruments supplier’s stock valued at $7,271,000 after purchasing an additional 30,835 shares in the last quarter. First Eagle Investment Management LLC grew its stake in InfuSystem by 14.7% in the fourth quarter. First Eagle Investment Management LLC now owns 537,214 shares of the medical instruments supplier’s stock valued at $5,662,000 after purchasing an additional 68,814 shares in the last quarter. Finally, Heartland Advisors Inc. grew its stake in InfuSystem by 17.6% in the third quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock valued at $4,820,000 after purchasing an additional 75,000 shares in the last quarter. Hedge funds and other institutional investors own 71.13% of the company’s stock.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.